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To explore basic mechanisms of action of pulmonary surfactant in preventing alveolar collapse, a 
first-principles analysis is done analyzing forces on the shared walls separating adjacent alveolar 
gas bubbles.  The analysis holds for concave alveolar models with either rounded, dome-like 
surfaces or flat, box-like surfaces.  The analysis also holds for neighboring alveoli of varying 
size and shape.  Surfactant action is characterized by two parameters describing reduction in 
surface tension vs. log concentration. The resulting equations describe the net pressure tending to 
shift the shared position of a wall, as a function of the perturbation from a balanced initial state.  
In the absence of surfactant, the bubbles exist in an unstable equilibrium.  Any perturbation 
causes runaway positive feedback such that one bubble shrinks and the other enlarges.  In the 
presence of surfactant having adequate concentration and potency the initial normal bubble 
volumes are maintained by stabilizing negative feedback.  With borderline surfactant activity 
there is stable partial enlargement of one bubble and partial shrinkage of the other bubble.  The 
present analysis shows quantitatively how pulmonary surfactant normally works to equalize the 
sizes of neighboring alveolar gas bubbles in small, local regions of lung.  Once a threshold 
surfactant effect is exceeded this local stability is robust.  However, inadequate surfactant can 
lead to microatelectasis, intrapulmonic shunting of venous blood past poorly alveoli, and arterial 
hypoxemia.  The presence of giant alveoli surrounded by smaller collapsed alveoli, as well as the 
presence of hyaline membranes, characteristic of respiratory distress syndrome of the newborn, 
are also explained by the underlying biomechanics. 
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Normal lung function depends upon the presence of a pulmonary surfactant, a complex mixture 
of detergent-like molecules that stabilizes the sizes of alveolar gas bubbles, presumably by 
reducing surface tension.  Lack of sufficient surfactant at birth results in respiratory distress 
syndrome (RDS) of the newborn, a severe lung disease that can be reversed by treatment with 
intrapulmonary natural or semi-synthetic surfactants1.  In patients experiencing prolonged 
cardiopulmonary bypass for cardiac surgery there can be patchy atelectasis associated with 
decreased pulmonary surfactant (“pump lung”)2.  There is also a decrease of surfactant in the 
lungs of cigarette smokers3 and in cases acute respiratory distress syndrome (ARDS) with 
surfactant insufficiency.   
 
Natural pulmonary surfactant is a mixture of dipalmitoylphosphatidylcholine (DPPC), other 
phospholipids, neutral lipids, hydrophilic and hydrophobic apoproteins (SP-A, B, C, and D), and 
other proteins4, 5.  In healthy individuals, pulmonary surfactant is secreted by Type II alveolar 
cells and distributes to the surfaces of alveolar gas bubbles.  The phospholipids have hydrophilic 
“heads” and hydrophobic “tails”, and are thought to distribute on the surface of the alveolar gas 
bubble with their tails facing the bubble lumen, reducing surface tension as a function of their 
concentration per unit area.  The surfactant layer can be oligolamellar, rather than a true 
monolayer layer6.  Natural lung surfactant contains less than 40% of the most effective, 
disaturated phospholipids, such as DPPC.  Accordingly, increased surfactant activity may happen 
by a “squeeze out” mechanism5, in which less effective surfactants in the mixture, such as 
unsaturated phosphatidylcholine (PC) and phosphatidylglycerol (PG) are squeezed out of the 
surface monolayer, if its surface area decreases, increasing or enriching the concentration of 
DPPC, which has two hydrophobic alkyl chains7 and can be over 100 times more effective than 
the corresponding monomeric phospholipids8.  This squeeze out model predicts that as bubble 
size decreases, the effective DPPC concentration increases, and in turn, the surface tension 
decreases. 
 
Classical studies9 repeated many times10-12 demonstrate that elastic recoil pressures in lungs 
inflated with saline solution are substantially less at any given volume than those measured in 
lungs inflated with air.  This simple experiment demonstrates air-water surface tension is 
responsible for a large part of the elastic recoil pressure of the lungs.  That is, the larger part of 
the total retraction forces of the lung is ascribable to forces of surface tension.  
 
Early on, 20th century textbooks of physiology described the tendency of alveolar gas bubbles to 
collapse, and the corresponding physiological importance of surfactant in reducing surface 
tension, using the law of Laplace (tension = transmural pressure  radius / 2) applied to two 
spherical alveolar gas bubbles, connected by branched tubular airways—a “ball and stick” or 






















Figure 1.  Traditional balloon and tube model explaining alveolar instability without 
surfactant.  At certain critical times in the ventilatory cycle there can be net transfer of 
gas from smaller to larger alveoli in the absence of pulmonary surfactant.  
 
 
An emergent property of this model and is that if a smaller Laplacian bubble of radius, r1, is 
connected internally to a larger one of radius, r2, with the same surface tension, T, then there is a 
tendency for unequal pressure, P1 = 2T/r1 > P2 = 2T/r2, to force air from the smaller bubble into 
the larger one, at least during certain brief intervals in the ventilation cycle when P1 > Paw > P2 
for common airway pressure, Paw .  
 
This hypothetical system exhibits an unstable equilibrium.  If r1 = r2 exactly, the interconnected 
bubbles remain the same size.  If one or the other radius is changed, however, the smaller one 
will collapse into the larger one, creating an abnormal state quite similar to that observed in 
respiratory distress syndrome (RDS) of the newborn, in which there is a deficiency of pulmonary 
surfactant and in which microscopically, a small number of hyperinflated alveoli are seen, 
surrounded by a larger number of collapsed alveoli14.   
 
In a general and qualitative way, it is suggested that pulmonary surfactant can stabilize this 
system by reducing surface tension, either in a crude sense by reducing surface tension to zero or 
to negligible levels, so that the Law of Laplace becomes irrelevant, or in a more sophisticated 
sense by reducing surface tension in an area-dependent manner, when a constant amount of 
surfactant is distributed over a varying alveolar surface area.  As alveolar radius, r, decreases, the 
area becomes less and the surfactant concentration increases, which in turn reduces surface 
tension, opposing the tendency of the smaller gas bubble to collapse.   
 
In addition to being qualitative, and not quantitative, this simple Laplacian model has been 
critically challenged by a number of thinkers.  Prange13 has suggested that “the Y-tube model of 
the alveolar inflation and the bunch-of-grapes model of alveolar anatomy deserve a place, not in 
P1 
P2 




our minds and textbooks, but in the museum of wrong ideas”.  This critique is based upon 
several major differences between the assumed architecture of the model and the actual 
microscopic anatomy of the lung.  In particular, (1) alveoli are not shaped like spheres; they are 
shaped like multifaced polyhedra, open on one side, with multiple flat sided facets. (2) Alveoli 
are not directly connected to the smallest tubular airways, but rather clustered together in 
alveolar ducts or sacs.  They do not resemble individual balloons; rather, they have a sponge-like 
open architecture, arranged around the common atrium of the alveolar sac. (3) Alveoli often 
share common walls and are often directly interconnected by small alveolar pores of Kohn.   
 
Fung15 has also emphasized that at the alveolar level the balloon and tube model is 
“topologically wrong” and “both sides of each pulmonary alveolar septum are exposed to air at 
the same pressure”.  Further issues with the balloon and tube model have been raised by Hills16, 
who suggested that “the validity of the conventional bubble model is clearly dependent on near-
zero surface tension (< 5 mN/m)”, as well as other shortcomings17.  Nevertheless, this model 
continues to be taught in the 21st century, appearing in review articles18, in textbooks19-21 and in 
online study guides, lecture notes, flashcards, and You-Tube videos (For examples, search “Law 
of Laplace and alveolar collapse”.) 
 
The present paper presents a revised and neoclassical model of alveolar collapse and stability 
that preserves the simplicity and explanatory power of the original two bubble model but 
circumvents some of its anatomic limitations.  This new model is also quantitative rather than 
qualitative.  The essential feature is that neighboring alveoli within the same alveolar sac (or 
back-to-back neighboring sacs) have shared, common walls between them, such that the forces 
created by surface tension in neighboring bubbles oppose each other.  In the absence of 
surfactant, any pair of side by side or back to back bubbles is unstable, because if one bubble 
gets slightly smaller, the opposing pressures on the shared wall will become unbalanced, shifting 
the wall further toward the smaller bubble.  Thereafter, owing to the tendency of surface tension 
to minimize the surface area, the smaller bubble will assume a roughly similar, but smaller 
shape, and the larger bubble will assume a roughly similar but larger shape, subject to local 
boundary conditions.  This cycle will be repeated in a runaway fashion, causing the arrangement 
of “giant alveoli”, surrounded by many smaller, mostly collapsed alveoli, which are 
characteristic of respiratory distress syndrome of the newborn.   
 
This simple system of adjacent bubbles is easy to analyze in terms of the underlying biophysics 
and may describe the essential features of alveolar collapse in conditions such as respiratory 
distress syndrome of the newborn.  What follows is a quantitative description of the underlying 
biomechanics for either round sided or flat sided alveolar models.  The dose-effect curve for 
surfactant and the critical amount of surfactant needed to stabilize the system are also specified 
quantitatively.  The bubble equations and the surfactant equations are combined to create a 








2.1 More atomically realistic model 
 
As an alternative to the traditional balloon and tube model, Figure 2 illustrates a more 
anatomically realistic, neoclassical model, which includes adjacent alveolar gas bubbles in a 
particular alveolar duct or sac.  These bubbles share walls with other alveoli, either in the same 
alveolar sac (bottom) or in a neighboring alveolar sac (top).  The alveolar gas bubbles are of an 
arbitrary, concave, or dome-like shape, resembling partial pohyhedra, having a characteristic 
length, s, such as the time-averaged diameter over one ventilatory cycle.  (The change in volume 
over a ventilatory cycle of normal quiet breathing is only about 7%**.)  The neighboring alveolar 
gas bubbles tend to make contact by way of the shared flat surfaces of the polyhedra (shaded 
region in Figure 2). 
 
Now consider a movable patch of the shared wall between bubbles 1 and 2 having an arbitrary 
shape and constant area, awall.  Let this patch be denoted W.  Note that W may or may not contain 
a small alveolar pore.  Consider also the partial perimeters, shown as dotted curves in Figure 2.  
These perimeters are selected such that the force of surface tension along each perimeter is 




** To estimate the change in diameter during normal quiet breathing, where volume, V, is proportional to the cube 


















.  For example, in an adult, we might 
have V = FRC + TV = 2500 ml and V = TV = 500 ml, with V/V = 1/5 and s/s  0.07.  Similarly, in a neonate we 





























Figure 2.  Sketch of alternative biomechanical model of three adjacent alveolar gas 
bubbles sharing common walls, some of which might include alveolar pores.  Target 
patch, W, of shared wall having area, awall, is shown as shaded region.  Airway pressure, 
P, is locally uniform.  The gas bubbles may have arbitrary, dome-like shapes, ranging 
from partial spheres to flat sided boxes.  Characteristic dimensions s1 and s2 may differ.  
The walls may be smooth or may be buckled or wrinkled in partial collapse. 
 
 
Let the partial circumference of this perimeter in a plane parallel to wall W in bubble 1 be 
denoted c1 , and let the area of the plane of the perimeter parallel to the surface of W be denoted 
A1 . Let the partial circumference of the corresponding perimeter in bubble 2 be denoted c2 , and 
let the corresponding plane area be denoted A2 .  For bubbles of characteristic lengths, s, the 
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corresponding shape factor is 4.62, and for a full hexagon, open at the bottom at one side, the 
shape factor is 3.85 (calculations not shown).  Most compact alveolar geometries would have 
shape factors near 4.**  Hence, in vivo, shape factors may differ modestly, but not greatly. 
 
If wall patch, W, moves from left to right in Figure 2, then the volume of bubble 1 will expand 
and the volume of bubble 2 will shrink.  Because the walls of each bubble have surface tension, 
they will adjust to form minimal surface area shapes of the same general design, such as 
hemispheres or boxes, depending on the local anatomical constraints provided by the tensile 
matrix of connective tissue in the alveolar septae.  However, the movement of the shared wall 
still allows one bubble to expand and the other bubble to contract. 
 
Now consider the balance of forces acting on W, with forces acting on area, awall, from left to 
right in Figure 2 considered positive.  In bubble 1 the force from internal pressure, P, on the 
shared wall is P awall .  This force is opposed by surface tension, T1, in bubble 1, which creates an 
inward directed force acting along the perimeter of the bubble in a direction normal W.  This 
counterbalancing horizontal force from wall tension opposes the force of gas pressure on W.  
The magnitude of the net force from bubble 1 pushing on W from left to right is 
 
𝐹1 = 𝑃𝑎𝑤𝑎𝑙𝑙 −  𝑇1𝑐1
𝑎wall
𝐴1
  .         (2) 
 
Here the total force of surface tension is T1c1.  The fraction 
𝑎𝑤𝑎𝑙𝑙
𝐴1
  describes the proportion of the 
total force of surface tension acing on W.  Similarly, the magnitude of the net force from bubble 
2 pushing on W from right to left is 
 
𝐹2 = 𝑃𝑎𝑤𝑎𝑙𝑙 − 𝑇2𝑐2
𝑎𝑤𝑎𝑙𝑙
𝐴2
  .         (3) 
 
Because the two alveoli are derived from the same alveolar sac or very closely neighboring 
alveolar sacs, as well as because of the presence of alveolar pores, the air pressure, P, has the 
same magnitude in both alveoli.  The net pressure difference across W in the positive, left to 

















 ,      (4) 
 
for shape factor, , which may change as a function of s1 and s2.  (A similar analysis for one 
sided, but not counterbalancing, retraction forces at plane interfaces was described in the year 
1975 by Reifenrath22 (pages 123-124)).  Now, without surfactant, if T1 = T2 = T, the common 
 









 , so that  = 3.  For tall, 
narrow open-bottom rectangles of short side, s, and tall side, b, the shape factor,  = (2b+s)/(bs), approaches 2 as 
short side span, s, approaches zero.  For short, wide open-bottom rectangles of wide side, s, and short side, b, the 
shape factor,  = (2b+s)/(bs), approaches infinity as b approaches zero.  If one bubble collapses into its neighbor 
there might be some systematic change in the shape factor, opposed to some degree by the effects of surface tension 
that minimize surface area and perimeters toward more compact configurations. 
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surface tension of water, and if 1 = 2 for simplicity, then equation (4) clearly implies positive 
feedback.  As the wall moves from left to right, bubble 1 will get bigger and bubble 2 will get 
smaller, further increasing the net positive pressure on W.   
 
To characterize the size relative changes of neighboring alveolar gas bubbles, let    denote the 
absolute value of the fractional change in bubble dimensions, 
|𝛥𝑠|
𝑠
 , caused by movement of W, 
where  s  is the average initial value of local alveolar dimensions during the ventilatory cycle, 
and |s| is the absolute value of septal shift in Figure 2.  In this case surfactant concentration in 
each bubble wall changes as a function of 𝜀1 =
|∆𝑠|
𝑠10
 and of 𝜀2 =
|∆𝑠|
𝑠20
 with subscript 0 indicating 
the initial conditions.  Then 𝑠1 = 𝑠10(1 + 𝜀1)  and 𝑠2 = 𝑠20(1 − 𝜀2).   
 
 
2.2 Surfactant effect 
 
A remarkable property of the surfactant that coats the walls of alveolar gas bubbles is that it 
reduces the surface tension by a factor of up to fifteen23-25.  Surfactants typically reduce surface 
tension in a concentration-dependent manner, as shown in Figure 3.  The semi-logarithmic 
relationship is that most frequently found experimentally8, 26, 27.  Surface tension of saline at 
37°C , Tmax, is about 70 mN/m
7.  For tiny concentrations of surfactant, there is no effect.  Then 
after a critical minimal concentration, c0 , is reached, the “breaking point” of the curve, surface 
tension decreases as a linear function of the logarithm of the concentration until a maximal 
reduction is achieved, after which further increases in surfactant concentration have no additional 
effect.  As shown in Figure 3, curves of this type can be described simply by the piecewise linear 
function of the log surfactant concentration, c , in the liquid phase as follows: 
 
𝑇 = 𝑇𝑚𝑎𝑥 , c < c0 
 
𝑇 = 𝑇𝑚𝑎𝑥 (1 − 𝛽
𝑙𝑛(𝑐/𝑐0)
𝑙𝑛(𝑐𝑚𝑎𝑥)/𝑐0)
) , c0  c  cmax       (5) 
 
𝑇 = 𝑇𝑚𝑎𝑥 (1 − 𝛽) , c > cmax , 
 
where  is the maximal fractional reduction in surface tension produced by a particular 































Figure 3.  Typical dose response curve for a surfactant redrawn from (Trillo, 2014)8.  
Dashed curve shows piecewise linear approximation.  Ln indicates the natural logarithm. 
 
  

























Initially, the time-averaged concentration of surfactant on the surface of each alveolar bubble is 
some specified nominal or normal value, cn , which we assume in the present model is constant 
over the many cycles of ventilation, such that for variable concentration, c(), we have  
𝑐𝑠2 = 𝑐𝑛𝑠𝑛
2  or   𝑐𝑠𝑛
2(1 + 𝜀)2 = 𝑐𝑛𝑠𝑛
2. , where, as before, the variable, , denotes the fractional 
change in gas bubble size.   The influence of relative area on local surfactant concentration 
during small changes in alveolar volume has been demonstrated experimentally28-30 and 
theoretically31.  In this case the concentration as a function of  is 𝑐 =
𝑐𝑛
(1+𝜀)2
, and in the critical 
range of interest to the right of the breaking point, c0  c  cmax , 
 

























).        (7) 
 
Introducing the dimensionless constants 
 



















  ,          (9) 
 
to describe the nominal concentration and potency of a particular surfactant, then 
 
𝑇 = 𝑇𝑚𝑎𝑥(𝑎 + 𝑏 𝑙𝑛(1 + 𝜀)).         (10) 
 
Constant, a , represents the fractional reduction in T before any wall shift, when  = 0.  That is,  
a = T/Tmax .  Moreover, accounting for surfactant effect, when the bubble dimension increases by  
  , surface tension increases, rather than remaining constant, as shown experimentally by Smith 






2.3 Combined force balance and surfactant effects 
 




that is caused by movement of W, where  s  is the average initial value of local alveolar 
dimensions in time during the ventilatory cycle.  In particular,  𝑠1 = 𝑠10(1 + 𝜀1)  and 𝑠2 =









 .         (11a) 
 
To add the effect of a modest change in shape factor, , which in view of the forgoing examples 
will be most likely within the range of about 3.5 to 4.5, as neighboring bubbles stretch and 
shrink; consider a simple linear model.  In this sub-model d/ds = k, a small constant.  Then 
𝜑1 = 𝜑10(1 + 𝑘𝜀1)  and  𝜑2 = 𝜑20(1 − 𝑘𝜀2) .  That is, as wall shift occurs, bubble 1 may 
become a little more rounded with  closer to 4, and bubble 2 may become a little more flattened 








 .        (11b) 
 
For neighboring bubbles differing in initial size but remaining similar in shape k = 0.  The goal 
in what follows is to explore the stability of the neighboring bubble system in response to small 
mechanical changes, , in the alveolar dimensions caused, for example, by slight differences in 
lung elastic recoil, or perhaps small transient differences in patency of respiratory bronchioles 
serving neighboring alveolar sacs.   
 
Substituting surfactant dependent surface tensions for T1 and T2 in Equation (11b),  
 






)  .    (12) 
 
For purposes of perturbation analysis for any particular pair of alveoli, consider an initial 
equilibrium, which may or may not be stable, as the starting point for the analysis.  In this 












 ≡ 𝐾 , a constant.  Now for purposes of perturbation analysis for any particular pair of 
alveoli, we can consider dimensionless pressure difference across a particular patch of shared 












Further, because of the wall shift with dimension s1 increasing and dimension s2 decreasing, each 
by the same absolute amount, s = 1s10 = 2s20, we have 𝜀2 =
𝑠10
𝑠20
𝜀1 ≡ 𝜆𝜀1 for constant  








        (13b) 
 
for −1 < 𝜀1 < 𝜆𝜀1 , as a function of 1 only. 
 
When the fractional change in bubble size, 𝜀1 = 0 , then 𝑝 = 0 , as expected. 
 
In this way the neighboring bubble model and the surfactant effect model can be combined to 
describe the critical equilibriums for airway collapse or stability in terms of runaway or 
compensatory motion of the shared wall.  All model parameters are defined on the basis of 
physics, anatomy, chemistry, and physiology.  There are no free parameters or arbitrary 
constants.   
 
 
2.4 Values of critical constants 
 
Analysis of experimental data can be done to find the values of constants  a  and  b  in Equation 
(13b).  For normal alveoli the surfactant concentration  cn  produces an in vivo surface tension of 
25 mN/m23 in vitro in experiments on surfactant bubble films, and values ranging from about 10 
to 25 mN/m in vivo33, 34.  Taking a value of 18 mN/m as the initial operating point for our model, 
and taking 70 mN/m as the surface tension for saline solution without surfactant, the value for 








≈ 0.257.         (14) 
 
All that is needed to estimate constant, b, are two measured points in the linear range of surface 
tension vs. log concentration, as described in the Appendix.  Point 1 represents a state of high 
surface tension and low surfactant concentration, and point 2 represents a state of lower surface 
tension and increased surfactant concentration.  As explained in the Appendix, the critical 
variables for data analysis are ln(c2/c1) and (T1 − T2)/Tmax, where Tmax is the surface tension of 
saline solution without surfactant.   
 





          (15) 
 
with Tmax = 70 mN/m for saline solution, and the other variables coming from two measured data 
points in a particular experiment, as shown in Table 1.  A virtue of this approach is that only 
relative values are needed, so concentration ratios can be inferred from measured bubble area 




Table 1 presents the results of this analysis to extract representative values of constants  a  and  b  
from nine published experimental studies involving natural and synthetic surfactants.  There is a 
range of effectiveness of the surfactants in terms of lumped parameter, b.  A middle value for use 




TABLE 1.  Curve fit constants from experimental data.  T = T1 − T2. 
 
Investigator (year) 2T/Tmax ln(c2/c1) b 
Hallman (1976) 1.229 1.609 0.763 
Barrow (1979) Fig 1 0.514 0.470 1.094 
Schurch (1989) Fig 5 0.529 0.693 0.763 
Seeger (1999) mixture 0.714 1.609 0.444 
Seeger (1999) Curosurf 0.457 0.511 0.895 
Walters (2000) 0.857 0.490 1.751 
Possmayer (2001) 0.714 0.211 3.390 
Scurch (2001) 0.714 0.375 1.906 
Trillo (2014) Fig 5 0.714 0.693 1.030 
      




To estimate the size difference factor, , consider that most neighboring alveoli in a cluster will 
be of similar size initially, with size difference factor, , being somewhat greater than 1.0 in 
some cases and somewhat less than 1.0 in other cases.  For an average or “typical” alveolus one 
would expect 1+   2.   
 
To estimate shape-change factor, k, we can expect on the basis of the forgoing geometric 
analysis and the various test shapes that a typical normal alveolar shape constant would be   4.  
This is the most likely scenario.  In cases where there is systematic change in shape factor with 
septal shift, the range of  would be perhaps 3.5 to 4.5.  Thus for  = 1 we would have 4.5/4 = 1 
 k, depending on which way the shape factor changes under local conditions.  Hence, we might 
expect k   0.125.  An approximate working value for a standard model would be k = 0.  To 








3.1 Linear approximations 
 
Before proceeding to exact numerical calculations, it is insightful to solve Equation (13b) 
analytically for some simplified test cases.  For small perturbations such as 
1 = s/s1 << 1, both the inverse function and the logarithmic function of can be simplified using 














𝜀3 + ⋯.        (17) 
 
Dropping terms for powers of  > 1 for small perturbations, the mathematics of Equation (13b) 
become more clear.  After using Equations (16) and (17) in Equation (13b), the dimensionless 
transmural pressure difference, as a function of the fractional expansion, 1, of bubble 1 is 
 
𝑝(𝜀1) ≈ (1 + 𝜆)(𝑎(1 − 𝑘) − 𝑏)𝜀1,        (18) 
 




≈ (1 + 𝜆)(𝑎(1 − 𝑘) − 𝑏).        (19) 
 
In the case of zero surfactant concentration the constant, a = 1, and the slope, , in Figure 3 is 
zero, so that b = 0.  The transmural pressure is proportional to any small volume offsets.  
Equations (18) and (19) imply positive feedback and runaway collapse over the full range −1   
 1.  However, for a particular surfactant compound, characterized by b > 0 , the value of  









  becomes smaller, as the surfactant concentration, cn, becomes greater.  
Eventually, for a(1 − k) < b , the slope of Equation (18) becomes less than zero over the full 
range −1  1  1.  Now if gas is shifted from bubble 1 to bubble 2 by some initial perturbation, 
the wall of bubble 2 will be pushed backward into bubble 1, restoring equilibrium.  Moreover, 
the greater the initial offset, 1, in the positive direction, the more the compensating negative 
pressure difference.  Similarly, for a negative offset, 1 < 0, Equation (18) implies that for  
a(1 − k) < b there will be compensating pressure in the positive direction.  Under these 






3.2 Shared wall pressure 
 
Figure 4 shows the exact solutions without surfactant (a = 1, b = 0) for shared wall pressure 
(Equation (13)) compared with the linear approximation (Equation (18)) as a function of the 
perturbation volume fraction, 1, for the two-bubble model.  The point at 1 = 0 is the neutral or 
equilibrium position.  In the absence of surfactant, however, the origin is an unstable 
equilibrium.  The same type of positive feedback and runaway collapse is predicted by both the 





Figure 4.  Perturbation analysis using transmural pressure without surfactant (a = 1, b = 
0) as a function of the fractional offset, 1, in linear dimension.  Curves represent exact 







= 21 𝑚𝑚𝐻𝑔 . Shape parameters  = 1 and k = 0. 
 
Figure 5 shows the exact solutions with a mid-range concentration of a surfactant with properties 
similar to that of biological pulmonary surfactant (Table 1).  The chart shows dimensionless 
transmural pressure, p, (Equation (13b)) and the linear approximation (Equation (18)) as a 
function of the fractional perturbation in alveolar size, 1 , for the side by side, two-bubble 
system.  Now, for either the exact or approximate solutions, when the perturbation is positive, 
the resulting wall pressure difference is negative, stabilizing the volumes of both bubbles.   A 
stable zero crossing point occurs at 1 = 0, since the slope of the function is negative at the zero 
crossing.  The magnitude of the compensating pressure is physiologically meaningful, on the 







































Figure 5.  Perturbation analysis with surfactant. a = 0.257, b = 1.34 , k = 0.0,  = 1 
(standard normal model).  A normal concentration and potency of surfactant can 
stabilize the system for all possible perturbations.  Curves represent exact and 






= 21 𝑚𝑚𝐻𝑔 . 
 
 
If an effective surfactant is present in sufficient concentrations, the origin is a stable equilibrium 
(Figure 5).  In general, if the wall pressure function, p(1) , is constrained to the “unstable 
quadrants” 1 and 3 in Cartesian coordinates, there will be an unstable equilibrium.  If the 
function p(1) is constrained to the “stable quadrants” 2 and 4 in Cartesian coordinates, there will 
be a stable equilibrium.  For the particular values of constants  a  and  b  in Figure 5 there is 
stability over the complete dynamic range of 1 from −1 to 1.  The results of Figure 5, which 
mimic the action of normal pulmonary surfactant, demonstrate the robustness of the surfactant 
effects over the entire range of possible wall shifts.   
 
The physics of the two-bubble system with adequate surfactant effect (a(1 − k) < b), is analogous 
to the physics of a pendulum in the gravitational field at the Earth’s surface or of a simple spring 
and mass system.  If the mass at the end of the pendulum or at the end of the spring is pulled in 
one direction, there will be a proportional restoring force directed toward the equilibrium 
position.  If the mass is pulled in the opposite direction there will be an oppositely signed 



































It is interesting to explore the region of transition between unstable and stable states for 
gradually increasing amounts of surfactant activity.  Figure 6 illustrates the effects of a series of 
surfactant concentrations, specified by decreasing values of parameter, a .  As surfactant action is 
increased, the slope of the shared wall pressure function gradually decreases from positive to 





Figure 6.  Perturbation analysis for increasing surfactant activity in terms of shared wall 
pressure.  Decreasing values of parameter, a, including a < 0, correspond to increasing 
surfactant concentration.  Shape parameters  = 1 and k = 0. 
 
A closer look at the transition region for the exact solutions reveals interesting behavior.  For 
example, when a = 0.57 and b = 0.43 in Equation (13b) the results in Figure 7 are obtained.  
There is one unstable equilibrium, and there are two stable equilibriums.  If a small positive wall 
shift, 1 > 0, occurs, then bubble 1 will continue to expand and bubble 2 will continue to shrink 
until the downward sloping zero crossing point in Figure 7 is reached.  There the system 
becomes stable, because further positive wall displacement results in negative feedback.  A 






































Figure 7.  Perturbation analysis for a borderline case (a = 0.57, b = 0.43,  = 1, k = 0).  
There are stable points at the two negatively sloping zero crossings near  0.5.  Note the 




3.3 Size and shape effects 
 
Sensitivity of the results in Figures 4 through 7 to changes in the initial size mismatch factor, , 
and the shape factor change term, k, can be appreciated both analytically, by inspection of 
Equations (18) and (19), and also numerically by evaluation of Equation (13b) for test cases.  
Analytically, the slope of the stability function at 1 = 0 is given by Equation (19) as  
𝑑𝑝/𝑑𝜀1 = (1 + 𝜆)(𝑎(1 − 𝑘) − 𝑏).  The initial size mismatch factor,  = s01/s02 , is always 
greater than zero.  Hence changes in  will influence the magnitude of the slope somewhat, but 
not the sign of the slope.  That is, to first order, changes in  will not change the threshold 
between stability and instability of the two-bubble system.  The system is essentially stable if 
𝑎(1 − 𝑘) < 𝑏 , and unstable otherwise.  Thus, changes in the absolute value of  k, representing 
shape-factor change with gas transfer from one bubble to the other, will cause modest changes in 
the threshold conditions for stability.  Values of k < 0 will make the system somewhat less 
stable, requiring greater surfactant activity to enforce stability.  Values of k > 0 will make the 
system somewhat more stable, requiring less surfactant activity to enforce stability.  The general 
requirement for some critical level of surfactant activity remains the same.   
 
Figure 8 shows examples of numerical solutions for the exact expression of Equation (13b), 
including nonlinear as well as linear effects.  In this highly sensitive, borderline stable case any 

































changes in slope both in the linear and nonlinear portions of the curve.  The same is true when 
the shape factor change term, k, is increased from 0 to 0.2 or decreased from 0 to − 0.2. 
Qualitative behavior of the two-bubble system with two stable equilibrium points at negatively 
sloping zero crossings is similar to that of the standard model in Figure 7. 
 
 
      
 
         (a)           (b) 
 
 
      
 
         (c)           (d) 
 
Figure 8.  Sensitivity analysis for size and shape difference factors    and  k  with  
a = 0.57, b = 0.43.  When initial size mismatch parameter, , or shape factor change 
parameter, k, is changed, there are still stable points at the two negatively sloping zero 
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The conventional qualitative explanation for the role of surfactant is that, once interconnected, 
smaller bubbles would have higher internal pressures, and hence gas would flow from smaller 
bubbles into larger ones until the smaller bubbles collapsed.  In this way it has been taught that 
surfactant protects against the collapse of alveoli and consequent formation of pulmonary edema, 
which would happen otherwise as the net collapse pressure draws fluid from capillaries into the 
alveolar spaces having smaller bubbles3, 35, leading to the shunting of venous blood past 
unventilated alveoli, and profound arterial hypoxemia.  In addition, the general reduction of 
surface tension by surfactant reduces lung recoil, ‘‘making breathing easy’’36. 
 
These teachings, however, are based on unrealistic anatomical assumptions that alveoli are 
spherical bubbles, connected only by tubular airways, rather than dome-like or box-like 
structures, often with flat sides, connected directly to the same alveolar sac and sharing common 
alveolar walls with their neighbors.  Moreover, the original balloon-and-tube model, based on the 
Law of Laplace for spherical bubbles, is only qualitative or at best semi-quantitative.  To fully 
understand the physiological mechanism that normally controls alveolar gas bubble size, and 
how it breaks down in conditions such as RDS, one needs to have a more anatomically realistic, 
quantitative model.   
 
The balance of forces described by Equations (13a) and (13b) provides a compact, quantitative 
mechanism for the local instability of alveolar neighboring gas bubble size in the absence of 
adequate surfactant, as well as for the local stability of neighboring alveolar gas bubble size in 
the presence of adequate surfactant.  The proposed mechanism for size stability works despite 
the many natural complexities of the underlying living system, which include the angled corners 
of non-spherical alveolar walls, deviation of the bubbles from a spherical shape at low surface 
tensions37, the action of surfactant activity-boosting apoproteins4, lipids23, or drugs38, possible 
degradation of surfactants by proteases or inhibition by plasma proteins24, and the existence of 
surface tension–area hysteresis loops3.  Moreover, the present approach easily incorporates 
possible molecular mechanisms other than simple monolayering for surface tension reduction.  
Such adjunct mechanisms include selective DPPC adsorption as well as recruitment of 
apoproteins during bubble compression from multilayered raft-like or iceberg-like reservoirs 
associated with the bubble surface7, 37.  The same goes for synthetic or semi-synthetic surfactant 
preparations, including additives to enhance their activity4.  Effects of such complexities can be 
incorporated into the lumped shape factor, , and the constants  a  and  b.   
 
An advantage of the present analysis and the associated mathematical model is that they 
accommodate neighboring alveoli of various sizes and shapes in the initial conditions.  Data exist 
showing that the ratio of alveolar depth to alveolar mouth diameter changes with inflation under 
certain conditions.  Klingele and Staub39 measured the ratio of maximum depth to the opening or 
mouth diameter of alveoli in anesthetized cates.  This ratio was constant (0.89  0.02) for 
inflation volumes at and above 50% of maximum lobe volume.  However, the ratio progressively 
increased for inflation volumes below 50%, indicating that the alveoli can became relatively 
narrower.  Such narrowing would tend to produce larger shape factors, , in the present 
21 
 
mathematical model.  There is one report that the alveolar septae may fold during deflation and 
unfold on inflation40; however the authors conclude that the “folds form de novo during 
experimental preparation; one need not postulate that septal folding was present in vivo.”  In 
addition, the ability of the present model to deal with initial conditions including different sized 
alveoli is useful in view of anatomic observations showing some differences in diameters of 
neighboring alveoli, even if the plane of section is taken into account41.   
 
It is important to appreciate that the present analysis and mathematical model describe 
neighboring alveoli in one alveolar sac.  There is nothing in the mathematics that requires 
average local alveolar diameters to be the same in different lobes of the lung.  The initial 
conditions are entirely local.  The initial diameters, s10 and s20, become part of the normalization 
factor for the scaled pressured difference, p, plotted in Figures 4 through 8.  In such cases there 
could well be different normal equilibrium sizes, s01 and s02, in different parts of the lung.  
However, local consistency in gas bubble size will still be maintained.  Similarly, the present 
revised and augmented bubble model applies equally well to small animals with smaller alveolar 
diameters43, 44 as well as to larger animals, such as humans, with larger alveolar diameters.  Also, 
the diameters s10 and s20 can be regarded as time averaged values throughout a ventilatory cycle, 
varying by about 10 percent (tidal volume / functional residual capacity).  In this sense the model 
is valid over a wide domain of space and time. 
 
Regarding shape factors of neighboring alveoli and divergence of shape factor values with septal 
shift, one can argue rather convincingly that curvature dependent Laplace forces will cause an 
individual partially flattened alveolar gas bubble to round-up and to become more uniformly 
curved as much as possible, subject to local boundary conditions.  Recall that actual gas/water 
interfaces are not preserved in the usual histologic preparations for light microscopy.  Hence, we 
think of alveolar air spaces as more angulated than they really are.  Shape factors would tend to 
bunch near the hemispherical value of = 4, as described previously.  Nevertheless, modest 
linear changes in the shape factor in either direction with sepal shifts, described mathematically 
by the constant, k, in Equations (11b) through (13b), cause only modest changes in stability 
criteria, as shown, for example, in Figure 8  Overall, the perturbation analysis described here 
model is robust with respect to differences in initial alveolar size and shape. 
 
In the absence of adequate surfactant activity, the neighboring bubble model of Figure 2 and 
Equation (13b) predicts local aggregation of gas volume into a few “giant” alveoli, with collapse 
of neighboring alveoli in the region. This pattern of pathology is exactly that observed in real-
world cases of respiratory distress syndrome of the newborn14, 42, which are characterized 
microscopically by multiple collapsed alveoli surrounding hyper-aerated alveoli, which are often 
lined with rims of amorphous protein deposits called hyaline membranes.  Could the side by side 
bubble model also explain the other hallmark feature of respiratory distress syndrome of the 
newborn, namely the presence of hyaline membranes, which are composed of proteins and 
occasionally fibrin42, lining the larger alveoli?  Perhaps so.   
 
Consider the shear stresses placed on a shared alveolar wall, containing a pulmonary capillary, as 
shown in Figure 9.  Here the circumference of the capillary includes three endothelial cells, 
surrounding a plasma filled lumen containing one red blood cell, shown in dark shading.  As one 
neighboring bubble enlarges and the other shrinks, one side of the capillary wall is stretched and 
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the other is compressed.  This action may tend to pull apart cell-cell junctions between capillary 
endothelial cells on the stretched side selectively.  Small gaps might well appear on the large 
bubble side of the capillary only.  These gaps would be sufficiently wide to allow leakage of 
plasma proteins including fibrin monomers and other clotting factors, but not wide enough to 
allow escape of the much larger red blood cells.  The leaked fibrin monomers would then tend to 
cross-link, forming a cell-free hyaline protein gel.  In this way the local asymmetry of shear 
stress may explain the appearance of hyaline membranes within the larger, expanded gas 


























Figure 9.  Scheme for explaining the formation of hyaline membranes.  Opposing shear 




Note also that without adequate surfactant the adjacent bubble model of Figure 2 implies a 
cascading sequence of failure for clusters of multiple adjacent bubbles: A, B, C, D, …, within the 
same alveolar sac.  If bubble A becomes transiently smaller, it will shrink and cause expansion of 
bubble B.  Now, bubble B is larger than its other neighbor, C, which will tend to collapse into 
bubble B as well.  If bubble B has more than the two neighbors, A and C, call them D, E, and F, 
originally of normal size, then those bubbles will also tend to collapse into B.  This sequence 
predicts the creation of single large bubbles, surrounded by multiple smaller ones in the absence 




of surfactant—exactly as is seen microscopically in cases of respiratory distress syndrome of the 
newborn42.   
 
The present theoretical treatment is, of course, highly simplified.  Nevertheless, it does explain 
many facets of normal and abnormal physiology, including why protection from alveolar 
collapse provided by surfactant is normally quite robust, regardless of initial bubble diameter, 
intrathoracic pressure, regional variation in lung ventilation, or modest differences in surfactant 
composition or effectiveness; why without surfactant there are many tiny collapsed alveoli, and a 
few hyper-expanded, giant alveoli in a low power microscopic field; why hyaline membranes 
tend to appear mostly in larger alveoli; why there is not massive pulmonary edema in the lungs 
of premature babies with RDS of the newborn; why an inadequate dose of surfactant can lead to 
partial reversal without complete normalization of alveolar size disparity; why alveolar size 
discrepancies between lung lobes are allowed; and why bats and shrews, reported to have very 
small alveolar diameters compared to other mammals44, can maintain these small alveolar 





The anatomically realistic adjacent bubble model described herein captures essential mechanisms 
underlying the action of pulmonary surfactant.  It provides quantitative expressions that 
incorporate the physics of surface tension to explain how air-breathing land animals survive, 
despite air-water surface tension in the lungs.  It also explains the pathophysiology and 
microscopic pathology of respiratory distress syndrome of the newborn, including the formation 
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APPENDIX: estimation of constant, b, from experimental data 
 
Consider two experimentally measured points 1 and 2 on the downward sloping linear range of 
the chart in Figure 3 and Equation (6).  Point 1 represents a state of high surface tension and low 
surfactant concentration, and point 2 represents a state of lower surface tension and increased 





 .          (20) 
 
In terms of the constants c0 and cmax, representing the smallest and largest surfactant 
concentrations on the complete linear portion of the curve in Figure 3 from Tmax to (1 − )Tmax , 
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Equating the two slopes, s < 0, in Equations (20) and (21), simplifying, and substituting  T  for 
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In this way one can estimate constant  b  from the measured relative surface tension reduction, 
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